Intraprocedural anticoagulation in patients on non-vitamin K antagonist oral anticoagulants undergoing catheter ablation for atrial fibrillation  

作　　者：童鸿[1] 

机构地区：[1]浙江省立同德医院心血管科

出　　处：《心电与循环》2020年第5期515-519,共5页Journal of Electrocardiology and Circulation

摘　　要：Atrial fibrillation(AF)catheter ablation,usually performed in patients on oral anticoagulation—either traditional vitamin K antagonists(VKAs)or non-vitamin K antagonist oral anticoagulants(NOACs)-entails contrasting risks:on the one hand,a risk of major bleeding,including hemopericardium,and on the other hand,a high transient procedure-related risk of thromboembolism that necessitates particularly rigorous anticoagulation throughout the procedure.

关 键 词：VITAMIN FIBRILLATION PATIENTS 

分 类 号：R541.75[医药卫生—心血管疾病]